Infergen gains expanded indication - ONA
Links shared publicly online about this topic.
- 1,042total visits
Infergen gains expanded indication - ONA
View full resource at oncologynurseadvisor.com
Tags: Liver Condition, Hepatitis, Hepatitis C, Hepatitis C Medication, FDA, Infergen, Rebetol
Most Recently Shared on July 6, 2010 at 3:53 pm By:
Infergen gains expanded indication http://goo.gl/fb/E1kfE
Erbitux Approved for Metastatic Head and Neck Cancer - MPR
empr.com — “Bristol-Myers Squibb announced that Erbitux (cetuximab) has gained an expanded indication for the treatment of metastatic head and neck cancer in combination with other chemotherapy.” View full resource at empr.com
Most Recently Shared on November 7, 2011 at 8:28 pm By:
Erbitux Gains Expanded Indication for Metastatic Head and Neck Cancer http://t.co/nqnyHzHm #oncology
Menactra Gains Indication for Immunization of Infants - MPR
empr.com — “The FDA has expanded the indication for Menactra (meningococcal [Groups A, C, Y and W-135] polysaccharide diphtheria toxoid conjugate vaccine; Sanofi Pasteur) to include a two-dose schedule for infants and children 9--23 months old.” View full resource at empr.com
Most Recently Shared on April 25, 2011 at 2:19 pm By:
MPR News: Menactra Gains Indication for Immunization of Infants: The FDA has expanded the indication for Menactr... http://bit.ly/ew0S93
Angioplasty, angiography, radial artery: Alternative angioplasty route gains favor - Health Key
healthkey.com — “Performing angioplasty and angiography through the radial artery of the arm is found to be as effective as the usual way, through the femoral artery of the leg, a study shows. But the radial route has fewer complications and is more comfortable for the patient, indicating its usage will expand.” View full resource at healthkey.com
Most Recently Shared on April 5, 2011 at 3:45 am By:
Hisham Rana, MD Doctor and Physician
Abstract Presentation: Alternative angioplasty route gains favor (ACC Meeting) http://bit.ly/fzFp2F - #health
Angioplasty, angiography, radial artery: Alternative angioplasty route gains favor - latimes.com
latimes.com — “Performing angioplasty and angiography through the radial artery of the arm is found to be as effective as the usual way, through the femoral artery of the leg, a study shows. But the radial route has fewer complications and is more comfortable for the patient, indicating its usage will expand.” View full resource at latimes.com
Most Recently Shared on April 5, 2011 at 12:10 am By:
Alternative angioplasty route gains favor http://lat.ms/fdTllx
Zostavax Gains Expanded Indication - MPR
empr.com — “Merck announced that Zostavax (varicella zoster vaccine, live, attenuated) has gained an expanded indication for the prevention of herpes zoster (shingles) in individuals 50--59 years of age.” View full resource at empr.com
Most Recently Shared on March 25, 2011 at 2:59 pm By:
MPR News: Zostavax Gains Expanded Indication: Merck announced that Zostavax (varicella zoster vaccine, live, att... http://bit.ly/iaTKS9
Infergen gains expanded indication - MPR
empr.com — “The FDA has approved expanded labeling for Infergen (consensus interferon, from Three Rivers) to include its daily use in combination with ribavirin for retreatment of chronic hepatitis C patients.” View full resource at empr.com
Most Recently Shared on July 6, 2010 at 3:33 pm By:
MPR News: Infergen gains expanded indication: The FDA has approved expanded labeling for Infergen (consensus inter... http://bit.ly/dBm75t
Benicar gains expanded indication for treatment of hypertension in children - MPR
empr.com — “The FDA has approved Benicar (olmesartan medoxomil tablets, from Daiichi Sankyo) for the treatment of hypertension in children and adolescents 6"16 years of age.” View full resource at empr.com
Most Recently Shared on February 11, 2010 at 3:32 pm By:
MPR News: Benicar gains expanded indication for treatment of hypertension in children: The FDA has approved Benica... http://bit.ly/c2FF0B
Biogen's Rituxan Label Expansion Delayed
zacks.com — “Biogen's rituxan label expansion delayed-biogen works towards gaining final approval for the expanded indication and are planning to continue final label discussions with the fda” View full resource at zacks.com
Most Recently Shared on November 20, 2009 at 5:09 pm By:
Rituxan shot down as part of first-line therapy for CLL http://bit.ly/8LKlRa
Byetta gains expanded indication for first-line treatment for type 2 diabetes - MPR
empr.com — “The FDA has approved Byetta (exenatide injection, from Amylin and Lilly), a GLP-1 receptor agonist, for use as monotherapy along with diet and exercise to improve glycemic control in adults with type 2 diabetes.” View full resource at empr.com
Most Recently Shared on November 2, 2009 at 2:25 pm By:
MPR News: Byetta gains expanded indication for first-line treatment for type 2 diabetes: The FDA has approved Byetta... http://bit.ly/4kc5TM
Xyzal gains expanded pediatric indication - MPR
empr.com — “The FDA has approved an expanded pediatric indication for Xyzal (levocetirizine dihydrochloride, from UCB and Sanofi-aventis) to include the relief of symptoms associated with perennial allergic rhinitis and the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in children 6 months of age.” View full resource at empr.com
Most Recently Shared on August 24, 2009 at 9:16 pm By:
MPR News: Xyzal gains expanded pediatric indication: The FDA has approved an expanded pediatric indicat.. http://bit.ly/izT8t
Isentress gains indication for use in treatment-nave HIV patients - MPR
empr.com — “The FDA has approved an expanded indication for Isentress (raltegravir tablets, from Merck), a HIV-1 integrase strand transfer inhibitor, in combination with other antiretrovirals for the treatment of human immunodeficiency virus (HIV-1) infection in adult patients, including treatment-nave patients.” View full resource at empr.com
Most Recently Shared on July 14, 2009 at 4:42 pm By:
MPR News: Isentress gains indication for use in treatment-naïve HIV patients: The FDA has approved an e.. http://tinyurl.com/mk9ako
Peg-Intron/Rebetol combination therapy gains expanded indication - MPR
empr.com — “The FDA has approved new labeling for Schering-Plough's Peg-Intron (peginterferon alfa-2b) and Rebetol (Ribavirin) combination therapy for treating chronic hepatitis C with compensated liver disease in patients 3 years of age.” View full resource at empr.com
Most Recently Shared on March 12, 2009 at 12:22 am By:
Peg-Intron/Rebetol combination therapy gains expanded indication: The FDA has approved new labeling for Schering.. http://tinyurl.com/b56rkd
Copaxone gains expanded indication - MPR
empr.com — “The FDA has approved an expanded indication for Copaxone (glatiramer acetate injection, from Teva) to include the treatment of patients who have experienced a first clinical episode and have magnetic resonance imaging (MRI) features consistent with multiple sclerosis (MS).” View full resource at empr.com
Most Recently Shared on March 3, 2009 at 9:23 pm By:
Copaxone gains expanded indication: The FDA has approved an expanded indication for Copaxone (glatiramer acetate.. http://tinyurl.com/agh5sm
Advertisement
